Screener
Sabra Healthcare SBRA Equity Method Income
Equity Method Income at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Stock-based compensation expense | 3,098 | 2,711 |
| Recovery of loan losses | (213) | (173) |
| Impairment of real estate | 440 | — |
| Income from unconsolidated joint ventures | (1,912) | (218) |
| Distributions of earnings from unconsolidated joint ventures | 1,657 | 2,368 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, prepaid expenses and other assets, net | (1,534) | (2,822) |
| Accounts payable and accrued liabilities | 2,113 | (4,706) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's equity method income?
- Sabra Healthcare (SBRA) reported equity method income of $1.91M in Q1 2026.
- How has Sabra Healthcare's equity method income changed year-over-year?
- Sabra Healthcare's equity method income increased by 777.1% year-over-year, from $218K to $1.91M.
- What is the long-term trend for Sabra Healthcare's equity method income?
- Over 3 years (2021 to 2025), Sabra Healthcare's equity method income has grown at a -48.0% compound annual growth rate (CAGR), from -$27.96M to $3.93M.
- What does equity method income mean?
- The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.
Ask your AI about Sabra Healthcare's equity method income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude